Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Apr;600(8):1821-1823.
doi: 10.1113/JP282581. Epub 2022 Mar 20.

Could angiotensin-II induced T-cell senescence exacerbate age-related vascular dysfunction?

Affiliations
Comment

Could angiotensin-II induced T-cell senescence exacerbate age-related vascular dysfunction?

Ravinandan Venkatasubramanian et al. J Physiol. 2022 Apr.
No abstract available

Keywords: T-cells; ageing; angiotensin II; arterial stiffness; cellular senescence; endothelial dysfunction; vascular ageing.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Mechanisms of Angiotensin II-induced senescent T-cells in cardiovascular disease development.
The findings by Trott et al. (2021) demonstrate that dysfunctional T-cells in old mice are involved in inducing vascular inflammation and associated vascular dysfunction. These age-related changes may be caused by Angiotensin II (Ang II)-induced cellular senescence of T-cells. Age-related increases in Ang II and senescent T-cells may be upstream mechanisms stimulating excess reactive oxygen species (ROS)-induced oxidative stress and chronic inflammation which amplify each other to reduce nitric oxide (NO) bioavailability, ultimately causing vascular dysfunction. Reduction in NO bioavailability is linked to impaired vascular function and increased blood pressure and hypertension risk. Taken together, suppressing potentially senescent T-cells may be a novel therapeutic approach to ameliorate inflammation and oxidative stress to favorably impact vascular function and reduce cardiovascular disease (CVD) risk with aging.

Comment on

References

    1. Trott DW, Machin DR, Phuong TTT, Adeyemo AO, Bloom SI, Bramwell RC, Sorensen ES, Lesniewski LA, Donato AJ. T cells mediate cell non-autonomous arterial ageing in mice. J Physiol. 2021. Aug;599(16):3973–3991. doi: 10.1113/JP281698. - DOI - PMC - PubMed
    1. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007. Oct 1;204(10):2449–60. doi: 10.1084/jem.20070657. Epub 2007 Sep 17. - DOI - PMC - PubMed
    1. Li R, Mi X, Yang S, Yang Y, Zhang S, Hui R, Chen Y, Zhang W. Long-term stimulation of angiotensin II induced endothelial senescence and dysfunction. Exp Gerontol. 2019. May;119:212–220. doi: 10.1016/j.exger.2019.02.012. Epub 2019 Feb 16. - DOI - PubMed
    1. Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, Ibrahim JG, Thomas NE, Sharpless NE. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009. Aug;8(4):439–48. doi: 10.1111/j.1474-9726.2009.00489.x. Epub 2009 May 22. - DOI - PMC - PubMed
    1. Wang M, Monticone RE, Lakatta EG. Proinflammation of aging central arteries: a mini-review. Gerontology. 2014;60(6):519–29. doi: 10.1159/000362548. Epub 2014 Aug 28. - DOI - PMC - PubMed

Publication types